PlainPharmaWatch

CMS Open Payments · Tool

Evolution Spine, LLC vs Creo Medical Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Evolution Spine, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,610, versus 789 for the other company. Its single largest recorded recipient represents 26.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Evolution Spine, LLC
HHI 1,610 · top recipient 26.4%
Ranked #834 of 1,838 companies by HHI
Creo Medical Inc.
HHI 789 · top recipient 17.4%
Ranked #1,122 of 1,838 companies by HHI

Payment Overview

Total Payments
$263.2K
% of Industry
0.0%
Transactions
96
Avg per Transaction
$2.7K
Recipients
96
Avg per Recipient
$2.7K
Payment Types
5
Top Payment Type
Royalty or License
Company B

Creo Medical Inc.

Total Payments
$263.8K
% of Industry
0.0%
Transactions
276
Avg per Transaction
$955.83
Recipients
276
Avg per Recipient
$955.83
Payment Types
4
Top Payment Type
Space Rental or Facility Fees

Highlighted values indicate the higher figure for each metric.

Total payments compared

Evolution Spine, LLC vs Creo Medical Inc. - total reported payments in CMS Open Payments PY2024

Creo Medical Inc.$263.8KEvolution Spine, LLC$263.2K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Evolution Spine, LLC

Royalty or License $198.7K

75.5%

Consulting Fee $38.5K

14.6%

Travel and Lodging $24.1K

9.2%

Food and Beverage $1.7K

0.6%

Gift $212.50

0.1%

Creo Medical Inc.

Space Rental or Facility Fees $131.2K

49.7%

Consulting Fee $78.0K

29.6%

Travel and Lodging $29.1K

11.0%

Food and Beverage $25.6K

9.7%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Evolution Spine, LLC

  1. 1

    Andrew A Indresano

    $69,590.44 · 17 txns

  2. 2

    Mark Valente

    $62,678.68 · 15 txns

  3. 3

    Aaron Buckland

    $29,136.91 · 11 txns

  4. 4

    Ripul Rajen Panchal

    $24,020.01 · 11 txns

  5. 5

    Maziyar Kalani

    $17,521.93 · 3 txns

Creo Medical Inc.

  1. 1

    UCSD MEDICAL CENTER

    $45,861.00 · 4 txns

  2. 2

    MOHAMED OTHMAN DR

    $31,390.86 · 20 txns

  3. 3

    NORIO FUKAMI DR

    $20,855.27 · 16 txns

  4. 4

    SALMAAN JAWAID DR

    $20,225.99 · 23 txns

  5. 5

    THE JOHNS HOPKINS HOSPITAL

    $20,000.00 · 2 txns

Summary Comparison

Metric Evolution Spine, LLC Creo Medical Inc.
Total Payments $263.2K $263.8K
% of Industry Total 0.0% 0.0%
Transaction Count 96 276
Avg per Transaction $2.7K $955.83
Recipient Count 96 276
Avg per Recipient $2.7K $955.83
Payment Type Count 5 4
Top Payment Type Royalty or License Space Rental or Facility Fees

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.